Grant: Discovery Grants Program - Individual
University of Waterloo
$29,000.00
Development of long-circulating nanoparticles for targeted drug delivery applications
EF 2013-14
Résumé
Polymeric nanoparticles represent a promising platform for targeted drug delivery applications. The central challenge in administering polymeric nanoparticles in vivo lies in the rapid particle clearance from the systemic circulation by the liver and spleen. As a result, only a small fraction of the administered nanoparticle dose is able to reach the targeted diseased cells and tissues. The nanoparticle clearance process is initiated when blood plasma proteins bind to the particle surface, making them visible to macrophages. The central aim of the proposed grant is to establish an active research program for developing drug-loaded polymeric nanoparticles that can effectively minimize plasma protein adsorption on the particle surface. It is hypothesized that the rate of nanoparticle clearance by macrophages can be substantially decreased by systemically optimizing the surface properties of polymeric nanoparticles. Our strategy involves modifying particle surfaces with natural polymers that mimic the protein-repelling surface properties of invasive pathogens. In the first phase of the proposed five-year research program, a platform technology will be developed for synthesizing self-assembled polymeric nanoparticles for targeted drug delivery. The second phase of the program will focusing on controlling the nanoparticle physicochemical properties to minimize protein adsorption on the particle surface. The nanoparticles developed from the proposed program may be used for a variety of clinical and biomedical applications. It is generally understood that targeted drug delivery holds great promise in pharmaceutical innovation for its ability to increase the effectiveness of existing drugs, decrease the necessity and thus cost for surgery and hospitalization and increase the quality of life of patients. The successful completion of the proposed NSERC discovery grant will help to secure Canada's position in nanobiotechnology and targeted drug delivery.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
372053-2009
Name nom
Gu, Frank
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2009
Award amount
29000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
4
Committee name en
Chem. & Metallurgical Eng.
Committee name fr
Génies chimique et métal.
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
5
Nb partie
5
Application title
Development of long-circulating nanoparticles for targeted drug delivery applications
Keyword
NSERC
Application summary
Polymeric nanoparticles represent a promising platform for targeted drug delivery applications. The central challenge in administering polymeric nanoparticles in vivo lies in the rapid particle clearance from the systemic circulation by the liver and spleen. As a result, only a small fraction of the administered nanoparticle dose is able to reach the targeted diseased cells and tissues. The nanoparticle clearance process is initiated when blood plasma proteins bind to the particle surface, making them visible to macrophages. The central aim of the proposed grant is to establish an active research program for developing drug-loaded polymeric nanoparticles that can effectively minimize plasma protein adsorption on the particle surface. It is hypothesized that the rate of nanoparticle clearance by macrophages can be substantially decreased by systemically optimizing the surface properties of polymeric nanoparticles. Our strategy involves modifying particle surfaces with natural polymers that mimic the protein-repelling surface properties of invasive pathogens. In the first phase of the proposed five-year research program, a platform technology will be developed for synthesizing self-assembled polymeric nanoparticles for targeted drug delivery. The second phase of the program will focusing on controlling the nanoparticle physicochemical properties to minimize protein adsorption on the particle surface. The nanoparticles developed from the proposed program may be used for a variety of clinical and biomedical applications. It is generally understood that targeted drug delivery holds great promise in pharmaceutical innovation for its ability to increase the effectiveness of existing drugs, decrease the necessity and thus cost for surgery and hospitalization and increase the quality of life of patients. The successful completion of the proposed NSERC discovery grant will help to secure Canada's position in nanobiotechnology and targeted drug delivery.